Does TALIMOGENE LAHERPAREPVEC Cause Vitiligo? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Vitiligo have been filed in association with TALIMOGENE LAHERPAREPVEC (Imlygic). This represents 0.5% of all adverse event reports for TALIMOGENE LAHERPAREPVEC.
7
Reports of Vitiligo with TALIMOGENE LAHERPAREPVEC
0.5%
of all TALIMOGENE LAHERPAREPVEC reports
0
Deaths
2
Hospitalizations
How Dangerous Is Vitiligo From TALIMOGENE LAHERPAREPVEC?
Of the 7 reports, 2 (28.6%) required hospitalization.
Is Vitiligo Listed in the Official Label?
Yes, Vitiligo is listed as a known adverse reaction in the official FDA drug label for TALIMOGENE LAHERPAREPVEC.
What Other Side Effects Does TALIMOGENE LAHERPAREPVEC Cause?
Off label use (196)
Pyrexia (135)
Product storage error (133)
Metastatic malignant melanoma (109)
Circumstance or information capable of leading to medication error (89)
Death (82)
Influenza like illness (82)
Fatigue (70)
Chills (68)
Malignant melanoma (64)
What Other Drugs Cause Vitiligo?
NIVOLUMAB (229)
PEMBROLIZUMAB (199)
RUXOLITINIB (157)
IPILIMUMAB (146)
DUPILUMAB (112)
RIBOCICLIB (102)
ADALIMUMAB (83)
LETROZOLE (55)
SECUKINUMAB (52)
METHOTREXATE (48)
Which TALIMOGENE LAHERPAREPVEC Alternatives Have Lower Vitiligo Risk?
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB
TALIMOGENE LAHERPAREPVEC vs TALQUETAMAB-TGVS
TALIMOGENE LAHERPAREPVEC vs TAMIFLU
TALIMOGENE LAHERPAREPVEC vs TAMOXIFEN
TALIMOGENE LAHERPAREPVEC vs TAMSULOSIN